SCHEMBL9256864

SCHEMBL9256864

COc1ccc(CC(=O)N2CCN(C(=S)SC)CC2)c(OC)c1OC

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.52
KMT2A Q03164 6/20 0.45
MEN1 O00255 5/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
SIGMAR1 Q99720 2/20 0.44
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 3/20 0.43
HTT P42858 2/20 0.43
PKM P14618 1/20 0.43
CYP1A2 P05177 1/20 0.40
CHRM2 P08172 1/20 0.40
SLC6A4 P31645 1/20 0.40
OPRD1 P41143 1/20 0.40
OPRK1 P41145 1/20 0.40
ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9252776 0.82 CYP2C19 (0.60) CYP2C19KMT2AMEN1SMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL9249587 0.81 CYP2C19 (0.59) CYP2C19KMT2AMEN1SMN1; SMN2ALDH1A1
SCHEMBL9252507 0.81 CYP2C19 (0.46) CYP2C19KMT2AMEN1SMN1; SMN2SIGMAR1
Hydrochloric Acid SCHEMBL9254215 0.80 KCNH2 (0.46) CYP2C19KMT2AMEN1SMN1; SMN2SIGMAR1
SCHEMBL9255037 0.79 ALDH1A1 (0.59) KMT2AMEN1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL9249214 0.76 ALDH1A1 (0.43) CYP2C19KMT2AMEN1SMN1; SMN2ALDH1A1
SCHEMBL9256748 0.76 CYP2C19 (0.49) CYP2C19KMT2AMEN1SMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL9255254 0.75 CYP2C19 (0.48) CYP2C19KMT2AMEN1SMN1; SMN2ALDH1A1
SCHEMBL9821357 0.74 CYP2C19 (0.62) CYP2C19KMT2AMEN1SMN1; SMN2ALDH1A1
SCHEMBL9254016 0.72 KDM4E (0.58) CYP2C19KMT2AMEN1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5446146-A Treatment of liver disorders NIPPON CHEMIPHAR CO., LTD. (JP) 1995-08-29 US disclosed
EP-0326379-B1 Therapeutic agent for liver disease and piperazine derivatives NIPPON CHEMIPHAR CO (JP) 1994-06-01 EP disclosed
US-5070089-A INHIBITION OF LIPID PEROXIDATION NIPPON CHEMIPHAR CO., LTD. (JP) 1991-12-03 US disclosed
EP-0326379-A2 Therapeutic agent for liver disease and piperazine derivatives NIPPON CHEMIPHAR CO., LTD. (JP) 1989-08-02 EP disclosed